Viatris Inc. (VTRS): Price and Financial Metrics

Viatris Inc. (VTRS): $11.14

0.12 (+1.09%)

POWR Rating

Component Grades














  • VTRS scores best on the Value dimension, with a Value rank ahead of 98.11% of US stocks.
  • The strongest trend for VTRS is in Value, which has been heading up over the past 179 days.
  • VTRS's current lowest rank is in the Momentum metric (where it is better than 17.48% of US stocks).

VTRS Stock Summary

  • VIATRIS INC's stock had its IPO on December 18, 1987, making it an older stock than 91.39% of US equities in our set.
  • Over the past twelve months, VTRS has reported earnings growth of -306.02%, putting it ahead of just 5.44% of US stocks in our set.
  • VIATRIS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 20.84%, greater than the shareholder yield of 92.61% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to VIATRIS INC, a group of peers worth examining would be CW, PKI, HUN, WAB, and TFX.
  • Visit VTRS's SEC page to see the company's official filings. To visit the company's web site, go to

VTRS Valuation Summary

  • VTRS's price/sales ratio is 0.7; this is 85.57% lower than that of the median Healthcare stock.
  • Over the past 243 months, VTRS's EV/EBIT ratio has gone up 12.5.

Below are key valuation metrics over time for VTRS.

Stock Date P/S P/B P/E EV/EBIT
VTRS 2022-11-01 0.7 0.6 16.3 21.8
VTRS 2022-10-31 0.7 0.6 16.1 21.7
VTRS 2022-10-28 0.7 0.6 16.0 21.6
VTRS 2022-10-27 0.7 0.6 15.7 21.5
VTRS 2022-10-26 0.7 0.6 15.9 21.5
VTRS 2022-10-25 0.7 0.6 15.6 21.4

VTRS Growth Metrics

    Its 5 year price growth rate is now at -62.22%.
  • Its 4 year revenue growth rate is now at 4.94%.
  • The 3 year price growth rate now stands at -51.32%.
Over the past 33 months, VTRS's revenue has gone up $5,227,800,000.

The table below shows VTRS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 16,728.3 3,333.1 803.6
2022-06-30 17,186.7 3,549.7 760.8
2022-03-31 17,647.7 3,306.6 167.7
2021-12-31 17,886.3 3,016.9 -1,269.1
2021-09-30 17,168.2 2,530 -1,921.1
2021-06-30 15,603.7 1,969.4 -2,046.9

VTRS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • VTRS has a Quality Grade of D, ranking ahead of 8.02% of graded US stocks.
  • VTRS's asset turnover comes in at 0.298 -- ranking 155th of 682 Pharmaceutical Products stocks.
  • CRIS, KDNY, and AGIO are the stocks whose asset turnover ratios are most correlated with VTRS.

The table below shows VTRS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.298 0.277 -0.030
2021-03-31 0.302 0.292 -0.027
2020-12-31 0.312 0.318 -0.011
2020-09-30 0.375 0.363 0.058
2020-06-30 0.375 0.356 0.052
2020-03-31 0.374 0.344 0.047

VTRS Price Target

For more insight on analysts targets of VTRS, see our VTRS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $20.21 Average Broker Recommendation 1.72 (Moderate Buy)

VTRS Stock Price Chart Interactive Chart >

Price chart for VTRS

VTRS Price/Volume Stats

Current price $11.14 52-week high $15.60
Prev. close $11.02 52-week low $8.42
Day low $10.90 Volume 5,012,000
Day high $11.14 Avg. volume 11,689,795
50-day MA $9.82 Dividend yield 4.31%
200-day MA $10.60 Market Cap 13.51B

Viatris Inc. (VTRS) Company Bio

Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania. The company was formed through the merger of Mylan and Upjohn, a division of Pfizer, on November 16, 2020. (Source:Wikipedia)

VTRS Latest News Stream

Event/Time News Detail
Loading, please wait...

VTRS Latest Social Stream

Loading social stream, please wait...

View Full VTRS Social Stream

Latest VTRS News From Around the Web

Below are the latest news stories about VIATRIS INC that investors may wish to consider to help them evaluate VTRS as an investment opportunity.

Biocon investors await smooth integration, execution of Viatris deal

The Q2 results are not too exciting. While revenue performance was decent, profitability was weaker

Livemint | November 22, 2022

What Does Viatris'' Debt Look Like?

Over the past three months, shares of Viatris'' Inc. (NASDAQ: VTRS ) moved higher by 8.16%. Before having a look at the importance of debt, let''s look at how much debt Viatris'' has. Viatris'' Debt According to the Viatris''''s most recent financial statement as reported on November 7, 2022, total debt is at $19.99 billion, with $18.72 billion in long-term debt and $1.26 billion in current debt. Adjusting for $646.70 million in cash-equivalents, the company has a net debt of $19.34 billion. Let''s define some of the terms we used in the paragraph above. Current debt is the portion of a company''s debt which is due within 1 year, while long-term debt … Full story available on

Benzinga | November 21, 2022

3 Unstoppable Growth Stocks to Buy and Hold

Three simple words can make you a lot of money over the long run: buy and hold. Here's why they chose Pfizer (NYSE: PFE), Thermo Fisher Scientific (NYSE: TMO), and Vertex Pharmaceuticals (NASDAQ: VRTX). Prosper Junior Bakiny (Pfizer): Pfizer has grown its top line at an incredible pace over the past two years.

Yahoo | November 19, 2022

Viatris And Oyster Point – Mylan All Over Again? (NASDAQ:OYST)

VTRS agreed to acquire OYST and Famy Life Sciences for combined $700 million to $750 million. OYST shareholders receive $11 plus a CVR (potentially worth $1-$2) per share.

Seeking Alpha | November 17, 2022

EQS-News: PAION AG enters partnership with Viatris and expands sales activities in Europe

EQS-News: PAION AG / Key word(s): Expansion PAION AG enters partnership with Viatris and expands sales activities in Europe 16.11.2022 / 11:40 CET/CEST The issuer is solely responsible for the content of this announcement. PAION AG enters partnership with Viatris and expands sales activities in Europe

Wallstreet:Online | November 16, 2022

Read More 'VTRS' Stories Here

VTRS Price Returns

1-mo 14.10%
3-mo 13.99%
6-mo N/A
1-year -8.97%
3-year N/A
5-year N/A
YTD -14.21%
2021 -26.12%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

VTRS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full VTRS Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.815 seconds.